Leonard Mazur
2022
In 2022, Leonard Mazur earned a total compensation of $1.2M as Chief Executive Officer and Executive Chairman at Citius Pharmaceuticals, a 51% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $170,000 |
|---|---|
| Option Awards | $620,056 |
| Salary | $400,000 |
| Total | $1,190,056 |
Mazur received $620.1K in option awards, accounting for 52% of the total pay in 2022.
Mazur also received $170K in non-equity incentive plan and $400K in salary.
Rankings
In 2022, Leonard Mazur's compensation ranked 2,698th out of 5,760 executives tracked by ExecPay. In other words, Mazur earned more than 53.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,698 out of 5,760 | 53rd |
Division Manufacturing | 1,500 out of 3,136 | 52nd |
Major group Chemicals And Allied Products | 690 out of 1,422 | 52nd |
Industry group Drugs | 643 out of 1,323 | 51st |
Industry Pharmaceutical Preparations | 464 out of 969 | 52nd |
Source: SEC filing on December 22, 2022.
Mazur's colleagues
We found three more compensation records of executives who worked with Leonard Mazur at Citius Pharmaceuticals in 2022.
News
Citius Pharmaceuticals CEO Leonard Mazur's 2023 pay jumps 66% to $2M
January 26, 2024
Citius Pharmaceuticals Chairman Myron Holubiak's 2022 pay falls 26% to $1.2M
December 22, 2022
Citius Pharmaceuticals CEO Myron Holubiak's 2021 pay jumps 91% to $1.7M
December 20, 2021
Citius Pharmaceuticals CEO Myron Holubiak's 2020 pay rises 15% to $875K
December 21, 2020
Citius Pharmaceuticals CEO Myron Holubiak's 2019 pay rises 12% to $764K
December 20, 2019
Citius Pharmaceuticals CEO Myron Holubiak's 2018 pay slips 2% to $681K
December 20, 2018